Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.
Takeuchi A, Endo M, Kawai A, Nishida Y, Terauchi R, Matsumine A, Aiba H, Nakamura T, Tandai S, Ozaki T, Hoshi M, Kayano D, Okuda M, Yamamoto N, Hayashi K, Miwa S, Igarashi K, Yoshimura K, Nomura A, Murayama T, Tsuchiya H.
Takeuchi A, et al. Among authors: kawai a.
Front Oncol. 2022 Sep 21;12:900010. doi: 10.3389/fonc.2022.900010. eCollection 2022.
Front Oncol. 2022.
PMID: 36212437
Free PMC article.